130 related articles for article (PubMed ID: 518222)
1. The treatment of pulmonary tuberculosis. Current options.
Addington WW
Arch Intern Med; 1979 Dec; 139(12):1391-5. PubMed ID: 518222
[TBL] [Abstract][Full Text] [Related]
2. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
3. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
4. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
5. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
Seung KJ; Gelmanova IE; Peremitin GG; Golubchikova VT; Pavlova VE; Sirotkina OB; Yanova GV; Strelis AK
Clin Infect Dis; 2004 Nov; 39(9):1321-8. PubMed ID: 15494909
[TBL] [Abstract][Full Text] [Related]
6. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
8. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
10. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
12. Present chemotherapy of tuberculosis.
O'Brien RJ
Semin Respir Infect; 1989 Sep; 4(3):216-24. PubMed ID: 2512603
[TBL] [Abstract][Full Text] [Related]
13. Short-course drug therapy for tuberculosis.
Stratton MA; Reed MT
Clin Pharm; 1986 Dec; 5(12):977-87. PubMed ID: 3542345
[TBL] [Abstract][Full Text] [Related]
14. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
[TBL] [Abstract][Full Text] [Related]
15. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
Brändli O; Dreher D; Morger D
Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
[TBL] [Abstract][Full Text] [Related]
16. [Antitubercular chemotherapy].
Jouveshomme S; Dautzenberg B
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
[TBL] [Abstract][Full Text] [Related]
17. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
[TBL] [Abstract][Full Text] [Related]
18. [Evolution of the treatment of tuberculosis].
Grassi C
Minerva Med; 1984 Mar; 75(11):569-72. PubMed ID: 6709194
[TBL] [Abstract][Full Text] [Related]
19. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
[TBL] [Abstract][Full Text] [Related]
20. Short-course treatment regimens for patients with tuberculosis.
Dutt AK; Stead WW
Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
